Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Umutlu

Showing results (121-130 of 315) with videos related to

Pageof 32
Sort By:
Plos One|January 10, 2015
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRIBenedikt Michael Schaarschmidt, Christian Buchbender, Felix Nensa, et al.
Nuclear Medicine Communications|June 15, 2026
Diagnostic value of integrated 18F-fluorodeoxyglucose PET/MRI in initial staging and recurrence detection of Ewing sarcomaMarcel Alexander Drews, Aleksandar Milosevic, Sebastian Zensen, et al.
European Radiology|May 16, 2016
Thoracic staging with <sup>18</sup>F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to <sup>18</sup>F-FDG PET/CT?Benedikt M Schaarschmidt, Johannes Grueneisen, Martin Metzenmacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate CancerRobert Seifert, Tugce Telli, Marcel Opitz, et al.
Plos One|February 23, 2017
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CTJulian Kirchner, Lino Morris Sawicki, Saravanabavaan Suntharalingam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 26, 2019
<sup>18</sup>F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trialYan Li, Benedikt Schaarschmidt, Lale Umutlu, et al.
BMC Infectious Diseases|September 18, 2021
What about the others: differential diagnosis of COVID-19 in a German emergency departmentDavid Fistera, Annalena Härtl, Dirk Pabst, et al.
European Journal of Radiology|August 19, 2022
Is preoperative CT-guided biopsy a valuable tool in the diagnostic workup of patients with visceral and retroperitoneal sarcoma?Georgios Luca Alatzides, Hannah Luisa Steinberg, Hans-Ulrich Schildhaus, et al.
Investigative Radiology|November 23, 2023
BOA: A CT-Based Body and Organ Analysis for Radiologists at the Point of CareJohannes Haubold, Giulia Baldini, Vicky Parmar, et al.
Plos One|September 19, 2014
Improved cerebral time-of-flight magnetic resonance angiography at 7 Tesla--feasibility study and preliminary results using optimized venous saturation pulsesKarsten H Wrede, Sören Johst, Philipp Dammann, et al.
Pageof 32

Showing results (121-130 of 315) with videos related to

Sort By:
Pageof 32
Plos One|January 10, 2015
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRIBenedikt Michael Schaarschmidt, Christian Buchbender, Felix Nensa, et al.
Nuclear Medicine Communications|June 15, 2026
Diagnostic value of integrated 18F-fluorodeoxyglucose PET/MRI in initial staging and recurrence detection of Ewing sarcomaMarcel Alexander Drews, Aleksandar Milosevic, Sebastian Zensen, et al.
European Radiology|May 16, 2016
Thoracic staging with <sup>18</sup>F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to <sup>18</sup>F-FDG PET/CT?Benedikt M Schaarschmidt, Johannes Grueneisen, Martin Metzenmacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate CancerRobert Seifert, Tugce Telli, Marcel Opitz, et al.
Plos One|February 23, 2017
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CTJulian Kirchner, Lino Morris Sawicki, Saravanabavaan Suntharalingam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 26, 2019
<sup>18</sup>F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trialYan Li, Benedikt Schaarschmidt, Lale Umutlu, et al.
BMC Infectious Diseases|September 18, 2021
What about the others: differential diagnosis of COVID-19 in a German emergency departmentDavid Fistera, Annalena Härtl, Dirk Pabst, et al.
European Journal of Radiology|August 19, 2022
Is preoperative CT-guided biopsy a valuable tool in the diagnostic workup of patients with visceral and retroperitoneal sarcoma?Georgios Luca Alatzides, Hannah Luisa Steinberg, Hans-Ulrich Schildhaus, et al.
Investigative Radiology|November 23, 2023
BOA: A CT-Based Body and Organ Analysis for Radiologists at the Point of CareJohannes Haubold, Giulia Baldini, Vicky Parmar, et al.
Plos One|September 19, 2014
Improved cerebral time-of-flight magnetic resonance angiography at 7 Tesla--feasibility study and preliminary results using optimized venous saturation pulsesKarsten H Wrede, Sören Johst, Philipp Dammann, et al.
Pageof 32